Thompson Siegel & Walmsley LLC Has $4.89 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Thompson Siegel & Walmsley LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 12.5% during the second quarter, Holdings Channel.com reports. The firm owned 15,228 shares of the company’s stock after selling 2,172 shares during the quarter. Thompson Siegel & Walmsley LLC’s holdings in HCA Healthcare were worth $4,892,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. FinTrust Capital Advisors LLC lifted its stake in HCA Healthcare by 26.7% in the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after purchasing an additional 35 shares in the last quarter. Lake Street Advisors Group LLC boosted its stake in HCA Healthcare by 1.3% during the 2nd quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock valued at $878,000 after purchasing an additional 35 shares during the last quarter. Financial Counselors Inc. raised its stake in HCA Healthcare by 1.4% during the 1st quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after buying an additional 36 shares during the last quarter. Premier Path Wealth Partners LLC increased its holdings in HCA Healthcare by 2.7% during the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after buying an additional 36 shares during the last quarter. Finally, Westside Investment Management Inc. boosted its position in shares of HCA Healthcare by 14.7% in the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock worth $93,000 after purchasing an additional 37 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on HCA shares. Truist Financial lifted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Royal Bank of Canada raised their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Oppenheimer upped their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Finally, Leerink Partners increased their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Stock Performance

HCA opened at $394.68 on Monday. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $403.05. The company has a market cap of $101.86 billion, a PE ratio of 19.67, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock has a 50-day moving average of $362.19 and a 200-day moving average of $338.12.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the prior year, the business earned $4.29 earnings per share. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.67%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock worth $6,407,273 in the last ninety days. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.